Cargando…
P1403: SI101-01 PHASE I/II STUDY EVALUATING SAFETY AND EFFICACY OF ALLOGENEIC SMART101 T-LYMPHOID PROGENITOR INJECTION TO ACCELERATE IMMUNE RECONSTITUTION AFTER T-CELL DEPLETED ALLOGENEIC HSCT
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430578/ http://dx.doi.org/10.1097/01.HS9.0000972500.66019.3c |
_version_ | 1785090999002857472 |
---|---|
author | Jan Boelens, Jaap Umair Mushtaq, Muhammad Mcguirk, Joseph Bauquet, Aurelie Simons, Laura Heimendinger, Pierre Gaudeaux, Pierre Andre, Isabelle Paillet, Juliette Negre, Olivier Soheili, Tayebeh-Shabi Oster, Sebastien van den Brink, Marcel R.M. Lehmann, Frederic Cavazzana, Marina Perales, Miguel-Angel |
author_facet | Jan Boelens, Jaap Umair Mushtaq, Muhammad Mcguirk, Joseph Bauquet, Aurelie Simons, Laura Heimendinger, Pierre Gaudeaux, Pierre Andre, Isabelle Paillet, Juliette Negre, Olivier Soheili, Tayebeh-Shabi Oster, Sebastien van den Brink, Marcel R.M. Lehmann, Frederic Cavazzana, Marina Perales, Miguel-Angel |
author_sort | Jan Boelens, Jaap |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10430578 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-104305782023-08-17 P1403: SI101-01 PHASE I/II STUDY EVALUATING SAFETY AND EFFICACY OF ALLOGENEIC SMART101 T-LYMPHOID PROGENITOR INJECTION TO ACCELERATE IMMUNE RECONSTITUTION AFTER T-CELL DEPLETED ALLOGENEIC HSCT Jan Boelens, Jaap Umair Mushtaq, Muhammad Mcguirk, Joseph Bauquet, Aurelie Simons, Laura Heimendinger, Pierre Gaudeaux, Pierre Andre, Isabelle Paillet, Juliette Negre, Olivier Soheili, Tayebeh-Shabi Oster, Sebastien van den Brink, Marcel R.M. Lehmann, Frederic Cavazzana, Marina Perales, Miguel-Angel Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10430578/ http://dx.doi.org/10.1097/01.HS9.0000972500.66019.3c Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
spellingShingle | Posters Jan Boelens, Jaap Umair Mushtaq, Muhammad Mcguirk, Joseph Bauquet, Aurelie Simons, Laura Heimendinger, Pierre Gaudeaux, Pierre Andre, Isabelle Paillet, Juliette Negre, Olivier Soheili, Tayebeh-Shabi Oster, Sebastien van den Brink, Marcel R.M. Lehmann, Frederic Cavazzana, Marina Perales, Miguel-Angel P1403: SI101-01 PHASE I/II STUDY EVALUATING SAFETY AND EFFICACY OF ALLOGENEIC SMART101 T-LYMPHOID PROGENITOR INJECTION TO ACCELERATE IMMUNE RECONSTITUTION AFTER T-CELL DEPLETED ALLOGENEIC HSCT |
title | P1403: SI101-01 PHASE I/II STUDY EVALUATING SAFETY AND EFFICACY OF ALLOGENEIC SMART101 T-LYMPHOID PROGENITOR INJECTION TO ACCELERATE IMMUNE RECONSTITUTION AFTER T-CELL DEPLETED ALLOGENEIC HSCT |
title_full | P1403: SI101-01 PHASE I/II STUDY EVALUATING SAFETY AND EFFICACY OF ALLOGENEIC SMART101 T-LYMPHOID PROGENITOR INJECTION TO ACCELERATE IMMUNE RECONSTITUTION AFTER T-CELL DEPLETED ALLOGENEIC HSCT |
title_fullStr | P1403: SI101-01 PHASE I/II STUDY EVALUATING SAFETY AND EFFICACY OF ALLOGENEIC SMART101 T-LYMPHOID PROGENITOR INJECTION TO ACCELERATE IMMUNE RECONSTITUTION AFTER T-CELL DEPLETED ALLOGENEIC HSCT |
title_full_unstemmed | P1403: SI101-01 PHASE I/II STUDY EVALUATING SAFETY AND EFFICACY OF ALLOGENEIC SMART101 T-LYMPHOID PROGENITOR INJECTION TO ACCELERATE IMMUNE RECONSTITUTION AFTER T-CELL DEPLETED ALLOGENEIC HSCT |
title_short | P1403: SI101-01 PHASE I/II STUDY EVALUATING SAFETY AND EFFICACY OF ALLOGENEIC SMART101 T-LYMPHOID PROGENITOR INJECTION TO ACCELERATE IMMUNE RECONSTITUTION AFTER T-CELL DEPLETED ALLOGENEIC HSCT |
title_sort | p1403: si101-01 phase i/ii study evaluating safety and efficacy of allogeneic smart101 t-lymphoid progenitor injection to accelerate immune reconstitution after t-cell depleted allogeneic hsct |
topic | Posters |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430578/ http://dx.doi.org/10.1097/01.HS9.0000972500.66019.3c |
work_keys_str_mv | AT janboelensjaap p1403si10101phaseiiistudyevaluatingsafetyandefficacyofallogeneicsmart101tlymphoidprogenitorinjectiontoaccelerateimmunereconstitutionaftertcelldepletedallogeneichsct AT umairmushtaqmuhammad p1403si10101phaseiiistudyevaluatingsafetyandefficacyofallogeneicsmart101tlymphoidprogenitorinjectiontoaccelerateimmunereconstitutionaftertcelldepletedallogeneichsct AT mcguirkjoseph p1403si10101phaseiiistudyevaluatingsafetyandefficacyofallogeneicsmart101tlymphoidprogenitorinjectiontoaccelerateimmunereconstitutionaftertcelldepletedallogeneichsct AT bauquetaurelie p1403si10101phaseiiistudyevaluatingsafetyandefficacyofallogeneicsmart101tlymphoidprogenitorinjectiontoaccelerateimmunereconstitutionaftertcelldepletedallogeneichsct AT simonslaura p1403si10101phaseiiistudyevaluatingsafetyandefficacyofallogeneicsmart101tlymphoidprogenitorinjectiontoaccelerateimmunereconstitutionaftertcelldepletedallogeneichsct AT heimendingerpierre p1403si10101phaseiiistudyevaluatingsafetyandefficacyofallogeneicsmart101tlymphoidprogenitorinjectiontoaccelerateimmunereconstitutionaftertcelldepletedallogeneichsct AT gaudeauxpierre p1403si10101phaseiiistudyevaluatingsafetyandefficacyofallogeneicsmart101tlymphoidprogenitorinjectiontoaccelerateimmunereconstitutionaftertcelldepletedallogeneichsct AT andreisabelle p1403si10101phaseiiistudyevaluatingsafetyandefficacyofallogeneicsmart101tlymphoidprogenitorinjectiontoaccelerateimmunereconstitutionaftertcelldepletedallogeneichsct AT pailletjuliette p1403si10101phaseiiistudyevaluatingsafetyandefficacyofallogeneicsmart101tlymphoidprogenitorinjectiontoaccelerateimmunereconstitutionaftertcelldepletedallogeneichsct AT negreolivier p1403si10101phaseiiistudyevaluatingsafetyandefficacyofallogeneicsmart101tlymphoidprogenitorinjectiontoaccelerateimmunereconstitutionaftertcelldepletedallogeneichsct AT soheilitayebehshabi p1403si10101phaseiiistudyevaluatingsafetyandefficacyofallogeneicsmart101tlymphoidprogenitorinjectiontoaccelerateimmunereconstitutionaftertcelldepletedallogeneichsct AT ostersebastien p1403si10101phaseiiistudyevaluatingsafetyandefficacyofallogeneicsmart101tlymphoidprogenitorinjectiontoaccelerateimmunereconstitutionaftertcelldepletedallogeneichsct AT vandenbrinkmarcelrm p1403si10101phaseiiistudyevaluatingsafetyandefficacyofallogeneicsmart101tlymphoidprogenitorinjectiontoaccelerateimmunereconstitutionaftertcelldepletedallogeneichsct AT lehmannfrederic p1403si10101phaseiiistudyevaluatingsafetyandefficacyofallogeneicsmart101tlymphoidprogenitorinjectiontoaccelerateimmunereconstitutionaftertcelldepletedallogeneichsct AT cavazzanamarina p1403si10101phaseiiistudyevaluatingsafetyandefficacyofallogeneicsmart101tlymphoidprogenitorinjectiontoaccelerateimmunereconstitutionaftertcelldepletedallogeneichsct AT peralesmiguelangel p1403si10101phaseiiistudyevaluatingsafetyandefficacyofallogeneicsmart101tlymphoidprogenitorinjectiontoaccelerateimmunereconstitutionaftertcelldepletedallogeneichsct |